CLOV vs EYPT · rev $1.37B vs rev $43.3M
Clover Health Investments Corp (CLOV) versus Eyepoint Pharmaceuticals Inc (EYPT) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Eyepoint Pharmaceuticals Inc (EYPT) is a biotechnology company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported EYPT revenue for 2024-12-31 was $43.3M. Net income was -$130.9M. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. EYPT currently screens at market cap $1.10B.
CLOV currently screens at market cap $1.55B. EYPT currently screens at market cap $1.10B.
Not investment advice. Open the CLOV and EYPT stock pages for the full models.
Not investment advice.